| Pharmaceutical active ingredients: |
| DihydroergocristineLomifylline |
| Available forms, composition and doses of Micerfin: |
| N / A |
| Micerfin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE54 - Dihydroergocristine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| LKM Laboratorio |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Iskedyl | Dihydroergocristine Mesylate; Raubasine | Pierre Fabre |
| Iskedyl Fort | Dihydroergocristine Mesylate; Raubasine | Pierre Fabre |
| Isquebral | Dihydroergocristine Mesylate; Raubasine | Faes Farma |
| Dipervina | Dihydroergocristine Mesylate; Vincamine; Vincamine Hydrochloride | Farma Lepori |
| Sandovene | Dihydroergocristine; Esculoside; Rutin | Sandoz |
| Almirid | Dihydroergocryptine Mesylate | Desitin Arzneimittel; Medagro International; Medicom International |
| Cripar | Dihydroergocryptine Mesylate | Adroka; Hormosan Pharma; Merz; Taurus Pharma |
| Myrol | Dihydroergocryptine Mesylate | Dorom |
| DHE | Dihydroergotamine | Inga Laboratories |
| DHE-Puren | Dihydroergotamine | Alpharma |